Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

por Friedman, Jay, Morisada, Megan, Sun, Lillian, Moore, Ellen C., Padget, Michelle, Hodge, James W., Schlom, Jeffrey, Gameiro, Sofia R., Allen, Clint T.
Publicado 2018

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells

por Clavijo, Paul E., Moore, Ellen C., Chen, Jianhong, Davis, Ruth J., Friedman, Jay, Kim, Young, Van Waes, Carter, Chen, Zhong, Allen, Clint T.
Publicado 2017

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms

por Moore, Ellen C., Sun, Lillian, Clavijo, Paul E., Friedman, Jay, Harford, Joe B., Saleh, Anthony D., Van Waes, Carter, Chang, Esther H., Allen, Clint T.
Publicado 2018